293 related articles for article (PubMed ID: 28176801)
1. MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.
Xu K; Chen G; Li X; Wu X; Chang Z; Xu J; Zhu Y; Yin P; Liang X; Dong L
Sci Rep; 2017 Feb; 7():41718. PubMed ID: 28176801
[TBL] [Abstract][Full Text] [Related]
2. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.
Schmidt KM; Dietrich P; Hackl C; Guenzle J; Bronsert P; Wagner C; Fichtner-Feigl S; Schlitt HJ; Geissler EK; Hellerbrand C; Lang SA
Neoplasia; 2018 Dec; 20(12):1198-1208. PubMed ID: 30404068
[TBL] [Abstract][Full Text] [Related]
5. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
[TBL] [Abstract][Full Text] [Related]
6. Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression.
You MH; Jeon MJ; Kim SR; Lee WK; Cheng SY; Jang G; Kim TY; Kim WB; Shong YK; Kim WG
Sci Rep; 2021 Jan; 11(1):2054. PubMed ID: 33479369
[TBL] [Abstract][Full Text] [Related]
7. When mTORC2-AKT signaling meets cell polarity.
Daulat AM; Borg JP
Cell Cycle; 2016 Nov; 15(22):3003-3004. PubMed ID: 27462958
[No Abstract] [Full Text] [Related]
8. Mitofusin2 Induces Cell Autophagy of Pancreatic Cancer through Inhibiting the PI3K/Akt/mTOR Signaling Pathway.
Xue R; Meng Q; Lu D; Liu X; Wang Y; Hao J
Oxid Med Cell Longev; 2018; 2018():2798070. PubMed ID: 30046371
[TBL] [Abstract][Full Text] [Related]
9. Calpain-activated mTORC2/Akt pathway mediates airway smooth muscle remodelling in asthma.
Rao SS; Mu Q; Zeng Y; Cai PC; Liu F; Yang J; Xia Y; Zhang Q; Song LJ; Zhou LL; Li FZ; Lin YX; Fang J; Greer PA; Shi HZ; Ma WL; Su Y; Ye H
Clin Exp Allergy; 2017 Feb; 47(2):176-189. PubMed ID: 27649066
[TBL] [Abstract][Full Text] [Related]
10. Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation.
Zanfardino P; Amati A; Petracca EA; Santorelli FM; Petruzzella V
Acta Myol; 2022; 41(4):201-206. PubMed ID: 36793649
[TBL] [Abstract][Full Text] [Related]
11. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Activation-Induced Downregulation of Mitofusin 2 in Human Peripheral Blood T Cells.
Dasgupta A; Chen KH; Munk RB; Sasaki CY; Curtis J; Longo DL; Ghosh P
J Immunol; 2015 Dec; 195(12):5780-6. PubMed ID: 26566676
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt promotes feedforward mTORC2 activation through IKKα.
Dan HC; Antonia RJ; Baldwin AS
Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448
[TBL] [Abstract][Full Text] [Related]
14. Mitofusin-2 in cancer: Friend or foe?
Ramaiah P; Patra I; Abbas A; Fadhil AA; Abohassan M; Al-Qaim ZH; Hameed NM; Al-Gazally ME; Kemil Almotlaq SS; Mustafa YF; Shiravand Y
Arch Biochem Biophys; 2022 Nov; 730():109395. PubMed ID: 36176224
[TBL] [Abstract][Full Text] [Related]
15. MFN2 silencing promotes neural differentiation of embryonic stem cells via the Akt signaling pathway.
Yi S; Cui C; Huang X; Yin X; Li Y; Wen J; Luan Q
J Cell Physiol; 2020 Feb; 235(2):1051-1064. PubMed ID: 31276200
[TBL] [Abstract][Full Text] [Related]
16. UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer.
Sane S; Srinivasan R; Potts RA; Eikanger M; Zagirova D; Freeling J; Reihe CA; Antony RM; Gupta BK; Lynch D; Bleeker J; Turaihi H; Pillatzki A; Zhou W; Luo X; Linnebacher M; Agany D; Zohim EG; Humphrey LE; Black AR; Rezvani K
Oncogene; 2023 May; 42(21):1763-1776. PubMed ID: 37037900
[TBL] [Abstract][Full Text] [Related]
17. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
[TBL] [Abstract][Full Text] [Related]
18. TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation.
Kim HK; Bhattarai KR; Junjappa RP; Ahn JH; Pagire SH; Yoo HJ; Han J; Lee D; Kim KW; Kim HR; Chae HJ
Nat Commun; 2020 Aug; 11(1):4012. PubMed ID: 32782388
[TBL] [Abstract][Full Text] [Related]
19. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
Ahn SY
BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
[TBL] [Abstract][Full Text] [Related]
20. Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.
Manning JR; Thapa D; Zhang M; Stoner MW; Traba J; Corey C; Shiva S; Sack MN; Scott I
Biochem J; 2019 Jun; 476(12):1713-1724. PubMed ID: 31138772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
